Methodology Study of Novel Outcome Measures to Assess Progression of ALS

CompletedOBSERVATIONAL
Enrollment

138

Participants

Timeline

Start Date

January 6, 2016

Primary Completion Date

July 27, 2018

Study Completion Date

August 1, 2019

Conditions
Amyotrophic Lateral Sclerosis
Trial Locations (21)

2129

Massachusetts General Hospital, MA, Charlestown

3000

UZ Leuven, Leuven

3584

UMC Utrecht, Utrecht

9007

Kantonsspital St. Gallen, Sankt Gallen

13125

Charite - Campus Virchow-Klinikum, Berlin

21287

Johns Hopkins Hospital, Baltimore

30322

The Emory Clinic, Atlanta

30625

Medizinische Hochschule Hannover, Hanover

33612

University of South Florida, Tampa

34295

Hopital Gui de Chauliac, Service de Neurologie, Montpellier

63110

Washington University School of Medicine, St Louis

75013

Groupe Hospitalier Pitie-Salpetriere, Paris

89081

Universitaetsklinikum Ulm, Ulm

92103

University of California San Diego Medical Center, San Diego

94115

California Pacific Medical Center, San Francisco

EC037

Penn State Milton S. Hershey Medical Center, Hershey

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

H3A 2B4

Montreal Neurological Institute Clinical Research Unit, Montreal

07743

Universitaetsklinikum Jena, Jena

Dublin 9

Beaumont Hospital, Dublin

S102JF

Royal Hallamshire Hospital, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY